Detalhe da pesquisa
1.
Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection.
Immunity
; 57(1): 40-51.e5, 2024 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38171362
2.
Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance.
Immunity
; 57(4): 890-903.e6, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518779
3.
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization.
Immunity
; 55(2): 341-354.e7, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990590
4.
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection.
Cell
; 164(3): 392-405, 2016 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26806128
5.
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.
Immunity
; 54(8): 1853-1868.e7, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331873
6.
Structural basis for Marburg virus neutralization by a cross-reactive human antibody.
Cell
; 160(5): 904-912, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25723165
7.
Mechanism of human antibody-mediated neutralization of Marburg virus.
Cell
; 160(5): 893-903, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25723164
8.
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.
Immunity
; 49(2): 363-374.e10, 2018 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30029854
9.
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection.
PLoS Pathog
; 18(1): e1010179, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990486
10.
Nur77 controls tolerance induction, terminal differentiation, and effector functions in semi-invariant natural killer T cells.
Proc Natl Acad Sci U S A
; 117(29): 17156-17165, 2020 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32611812
11.
Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
Proc Natl Acad Sci U S A
; 115(1): E82-E91, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29255018
12.
Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2.
J Virol
; 93(14)2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31068427
13.
Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection.
J Virol
; 93(8)2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728263
14.
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap.
PLoS Pathog
; 14(8): e1007204, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30138408
15.
Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates.
J Infect Dis
; 218(suppl_5): S565-S573, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982718
16.
Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.
J Virol
; 90(8): 3890-3901, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26819310
17.
IL-15 regulates homeostasis and terminal maturation of NKT cells.
J Immunol
; 187(12): 6335-45, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22084435
18.
Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individuals.
Nat Commun
; 13(1): 3178, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35676279
19.
Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency.
J Clin Invest
; 132(15)2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35588376
20.
SARS-CoV-2 B cell receptor signatures in at-risk populations.
J Clin Invest
; 131(1)2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216735